Quality Oncology Practice Initiative (QOPI) participation as a means to physician engagement, performance improvement, and delivery of safe and high-quality cancer care.

Authors

null

Gurkamal S. Chatta

Virginia Mason Medical Center, Seattle, WA

Gurkamal S. Chatta, David Michael Aboulafia, Amy Brockmeyer, Molly Bumpus, Irina Dimitrova, Cathy Goetsch, Andrew Jacobs, Bruce S. Lin, Thomas William Malpass, Craig R. Nichols, Vincent J. Picozzi, Nanette Robinson, Prakash Vishnu, Joseph Grant F. Rosales

Organizations

Virginia Mason Medical Center, Seattle, WA, Virginia Mason Community Clinical Oncology Program, Seattle, WA, Medical Oncology Associates, Seattle, WA

Research Funding

No funding sources reported

Background: High quality and safe medical care has been a consistent goal of the medical community at Virginia Mason Medical Center (VMMC). The Am Soc of Clinical Oncology (ASCO) has set out a list of criteria as part of Its Quality Oncology Practice Initiative (QOPI), which are increasingly being adopted as standards for quality measurement in the Oncology community. Our practice at VMMC participated in the QOPI quality metric survey, with the intent of measuring and enhancing cancer care delivery. Methods: We participated in the web-based QOPI quality metric during the September, 2013 and April, 2014 sessions. Chart abstraction was shared by the providers. Following the Sept session, our performance was analyzed, and targeted areas of improvement were collectively identified by all providers. Following the April session, the clinical note format was changed to incorporate a standard template, addressing areas of underperformance. Results: In the September 2013 session, the primary areas of underperformance were assessment of: a) pain, b) emotional distress, c) performance status (PFS), and d) documentation of staging. Following the April 2014 session, we noted improved performance in all these assessments. Thus, pain reporting rates improved from 40.6 to 61.2%; emotional distress screening from 37.3% to 42.8%; PFS documentation from 42.6 to 53.7%; and staging at initial diagnosis from 74.6% to 80.9%. However our areas of underperformance continued to lag 10 to 30% behind QOPI aggregate reporting rates. With the introduction of a structured note in the electronic medical record (EMR), further improvements are expected the results of which will be reported at the time of the meeting. On the positive side, chemotherapy education and discussion of risk/benefit were consistently areas of superior performance in our practice with our reporting rates being 10 to 40% higher than the QOPI aggregate. Conclusions: QOPI participation is a useful tool for improving and sustaining a high level of practice performance in oncology. Structured notes in the EMR maybe indispensable for maintaining a high level of compliance with performance measures.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cost, Value, and Policy in Quality and Practice of Quality

Track

Practice of Quality,Cost, Value, and Policy in Quality

Sub Track

Involving Patients in Quality Care

Citation

J Clin Oncol 32, 2014 (suppl 30; abstr 80)

DOI

10.1200/jco.2014.32.30_suppl.80

Abstract #

80

Poster Bd #

C16

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Quality of colorectal and anal cancer care delivered during the COVID pandemic.

First Author: Melanie Lynn Powis

Abstract

2023 ASCO Quality Care Symposium

The use of mobile electronic prescribing to drive quality of oncology care delivery.

First Author: Stephen Speicher